Lapatinib
About
Therapy type: Targeted therapy
Therapy strategy: HER2 inhibition
Mappings
NCI Thesaurus: Lapatinib (coding:ncit:C26653)
RxNorm: lapatinib (coding:rxcui:480167, coding:omop:1359548)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) HC (1) | HER2-positive | Invasive Breast Carcinoma | Capecitabine, Lapatinib | |
| FDA (2) | ER positive, HER2-positive | Invasive Breast Carcinoma | Lapatinib, Letrozole | |
| FDA (2) | HER2-positive, PR positive | Invasive Breast Carcinoma | Lapatinib, Letrozole | |
| FDA (2) | ER positive, HER2-positive, PR positive | Invasive Breast Carcinoma | Lapatinib, Letrozole |